Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Singh

Showing results (31-40 of 444) with videos related to

Pageof 45
Sort By:
Indian Journal of Experimental Biology|May 22, 2002
Patterns of inversion polymorphism in three species of the Drosophila melanogaster species groupB N Singh
The American Journal of Cardiology|September 25, 1990
Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarctionB N Singh
The American Journal of Cardiology|November 24, 1999
Overview of trends in the control of cardiac arrhythmia: past and futureB N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs?B N Singh
British Journal of Pharmacology|February 1, 1971
Explanation for the discrepancy in reported cardiac electrophysiological actions of diphenylhydantoin and lignocaineB N Singh
Journal of Cardiovascular Electrophysiology|October 1, 1995
Expanding indications for the use of Class III agents in patients at high risk for sudden deathB N Singh
American Heart Journal|October 1, 1983
Amiodarone: historical development and pharmacologic profileB N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Morbidity and mortality in cardiovascular disorders: impact of reduced heart rateB N Singh
The American Journal of Cardiology|April 1, 1989
When is QT prolongation antiarrhythmic and when is it proarrhythmic?B N Singh
The American Journal of Cardiology|August 1, 1991
Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study GroupB N Singh
Pageof 45

Showing results (31-40 of 444) with videos related to

Sort By:
Pageof 45
Indian Journal of Experimental Biology|May 22, 2002
Patterns of inversion polymorphism in three species of the Drosophila melanogaster species groupB N Singh
The American Journal of Cardiology|September 25, 1990
Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarctionB N Singh
The American Journal of Cardiology|November 24, 1999
Overview of trends in the control of cardiac arrhythmia: past and futureB N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs?B N Singh
British Journal of Pharmacology|February 1, 1971
Explanation for the discrepancy in reported cardiac electrophysiological actions of diphenylhydantoin and lignocaineB N Singh
Journal of Cardiovascular Electrophysiology|October 1, 1995
Expanding indications for the use of Class III agents in patients at high risk for sudden deathB N Singh
American Heart Journal|October 1, 1983
Amiodarone: historical development and pharmacologic profileB N Singh
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Morbidity and mortality in cardiovascular disorders: impact of reduced heart rateB N Singh
The American Journal of Cardiology|April 1, 1989
When is QT prolongation antiarrhythmic and when is it proarrhythmic?B N Singh
The American Journal of Cardiology|August 1, 1991
Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study GroupB N Singh
Pageof 45